Cohance Lifesciences Ltd Share Price

₹538.15 7.80 (1.47%) BSE
as updated on 16-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:527.35
  • Day's High:545.00

  • 52 Week Low521.45
  • 52 Week High1328.20

Cohance Lifesciences Ltd's key Fundamentals

Market Cap ₹20,289 Cr.
P/E Ratio 81.9
TTM EPS 7.3
P/B Ratio 5.36
ROE 13.87
Debt to Equity 0.05
Face Value 1
BVPS 115.3
3 Year Sales Growth -3.20%

Cohance Lifesciences Ltd's Share Price Returns

1 Day 1.47%
1 Week 0.30%
1 Month -12.80%
3 Months -44.50%
6 Months -45.70%
1 Years -57.60%
3 Years 11.80%
5 Years 24.70%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Cohance Lifesciences Ltd Shareholding Pattern

Promoters

(57.49%)

Institutions

(27.34%)

Non-Institutions

(15.17%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Cohance Lifesciences Ltd

Suven Pharmaceuticals Limited, a company incorporated in November 2018, has become Wholly Owned Subsidiary of Suven Life Sciences Limited, effective February 2019. Suven Life Sciences Limited, post the Board meeting on February 5, 2019, announced demerger of Suven Life Sciences Limited into: Suven Life Sciences Limited, the demerged entity, to continue innovative research focused on Central Nervous System (CNS) disorders to meet huge unmet global medical needs. Suven Pharmaceuticals Limited, the resultant entity, to continue the CRAMS business operations. The Scheme of Arrangement has since been approved by the National Company Law Tribunal (NCT), Hyderabad bench vide its order on 6th January 2020.

Pursuant to the Scheme of Arrangement between Suven Life Sciences Limited (‘Demerged Company’), Suven Pharmaceuticals Limited (‘Resulting Company’) and their respective shareholders and creditors, duly approved by the National Company Law Tribunal (NCLT), Hyderabad Bench, vide its Order dated 06th January, 2020, the Demerged Undertaking (as defined in the Scheme) of the Demerged Company has been demerged from Suven Life Sciences Limited and the same has been transferred to and vested in Suven Pharmaceuticals Limited with effect from 1st October, 2018, being the Appointed Date fixed in the said Scheme of Arrangement.

The Scheme, has become operative from the Appointed Date i.e., 1st October, 2018, but has become effective on 9th January, 2020 being the date on which certified copies of the Order of the NCLT, Hyderabad Bench sanctioning the Scheme was filed with the Registrar of Companies, Hyderabad, Telangana, both by the Demerged Company and Resulting Company.

Business area of the company

The company is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Business segments

  • Pharmaceutical Solutions
  • Active Pharma ingredients
  • Intermediates
  • Formulations
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 527.35
  • Day's High: 545.00

  • 52 Week Low521.45
  • 52 Week High1328.20

Cohance Lifesciences Ltd's key Fundamentals

Market Cap ₹20,289 Cr.
P/E Ratio 81.9
TTM EPS 7.3
P/B Ratio 5.36
ROE 13.87
Debt to Equity 0.05
Face Value 1
BVPS 115.3
3 Year Sales Growth -3.20%

Cohance Lifesciences Ltd's Share Price Returns

1 Day 1.47%
1 Week 0.30%
1 Month -12.80%
3 Months -44.50%
6 Months -45.70%
1 Years -57.60%
3 Years 11.80%
5 Years 24.70%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×